ScinoPharm Taiwan, Ltd. (TPE:1789)

ScinoPharm Taiwan Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,640	17,436	20,876	20,124	19,492	22,813
Market Cap Growth	-41.38%	-16.48%	3.73%	3.25%	-14.56%	8.46%
Enterprise Value	11,271	14,136	17,530	16,527	16,275	19,607
Last Close Price	17.25	21.61	25.60	24.38	23.17	26.56
PE Ratio	69.14	51.38	72.72	56.98	80.06	80.88
Forward PE	-	108.27	63.98	52.60	115.41	115.41
PS Ratio	4.27	5.12	6.55	6.17	7.06	7.40
PB Ratio	1.33	1.66	2.01	1.93	1.85	2.17
P/TBV Ratio	1.33	1.66	2.02	1.93	1.86	2.17
P/FCF Ratio	55.67	37.04	-	37.93	99.76	29.77
P/OCF Ratio	24.52	23.22	90.32	26.01	38.23	24.11
EV/Sales Ratio	3.53	4.15	5.50	5.06	5.89	6.36
EV/EBITDA Ratio	15.64	17.85	23.07	19.93	24.83	25.99
EV/EBIT Ratio	51.57	44.03	55.74	40.76	56.39	52.18
EV/FCF Ratio	46.00	30.03	-	31.15	83.29	25.59
Debt / Equity Ratio	0.07	0.06	0.06	0.07	0.05	0.06
Debt / EBITDA Ratio	1.00	0.83	0.80	0.80	0.83	0.75
Debt / FCF Ratio	2.95	1.44	-	1.28	2.85	0.75
Asset Turnover	0.27	0.29	0.27	0.28	0.24	0.26
Inventory Turnover	1.07	1.32	1.46	1.59	1.14	1.49
Quick Ratio	3.41	6.24	6.52	6.16	8.04	6.59
Current Ratio	5.34	8.61	8.75	7.87	10.73	8.62
Return on Equity (ROE)	1.98%	3.25%	2.76%	3.37%	2.31%	2.71%
Return on Assets (ROA)	1.14%	1.70%	1.66%	2.15%	1.53%	2.00%
Return on Capital (ROIC)	1.24%	1.81%	1.78%	2.28%	1.63%	2.11%
Return on Capital Employed (ROCE)	2.00%	2.90%	2.90%	3.70%	2.60%	3.40%
Earnings Yield	1.50%	1.95%	1.38%	1.75%	1.25%	1.24%
FCF Yield	1.80%	2.70%	-0.18%	2.64%	1.00%	3.36%
Dividend Yield	2.10%	1.62%	1.17%	1.48%	2.07%	1.88%
Payout Ratio	115.91%	69.91%	99.17%	107.46%	162.39%	75.69%
Buyback Yield / Dilution	-3.77%	-0.07%	0.04%	-0.05%	-0.01%	-0.01%
Total Shareholder Return	-1.67%	1.55%	1.22%	1.43%	2.06%	1.87%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.